The Biggest Psychedelic News This Week – October 9th
Weekly psychedelic news: Psychedelics could treat OCD, Novartis abandons study and Cybin Inc moves to acquire Small Pharma
Weekly psychedelic news: Psychedelics could treat OCD, Novartis abandons study and Cybin Inc moves to acquire Small Pharma
In yet another eventful week in the psychedelics sphere, more clear signs depict psychedelics’ popularity and acceptance.
SABI Mind announces the launch of the Global Psychedelic Survey (GPS) to provide English-speaking adults from around the globe with the opportunity to participate in the most extensive assessment of global psychedelic use to date.
End of content
End of content
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.